- Home
- BKH vs QURE Comparison
BKH vs QURE Comparison
Compare BKH & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKH
- QURE
- Stock Information
- Founded
- BKH 1941
- QURE 1998
- Country
- BKH United States
- QURE Netherlands
- Employees
- BKH N/A
- QURE N/A
- Industry
- BKH Electric Utilities: Central
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- BKH Utilities
- QURE Health Care
- Exchange
- BKH Nasdaq
- QURE Nasdaq
- Market Cap
- BKH 4.4B
- QURE 4.3B
- IPO Year
- BKH N/A
- QURE 2007
- Fundamental
- Price
- BKH $69.55
- QURE $30.76
- Analyst Decision
- BKH Buy
- QURE Strong Buy
- Analyst Count
- BKH 3
- QURE 13
- Target Price
- BKH $71.00
- QURE $62.33
- AVG Volume (30 Days)
- BKH 1.1M
- QURE 4.6M
- Earning Date
- BKH 11-05-2025
- QURE 11-10-2025
- Dividend Yield
- BKH 3.89%
- QURE N/A
- EPS Growth
- BKH 7.21
- QURE N/A
- EPS
- BKH 3.95
- QURE N/A
- Revenue
- BKH $2,271,600,000.00
- QURE $15,751,000.00
- Revenue This Year
- BKH $10.45
- QURE N/A
- Revenue Next Year
- BKH $3.32
- QURE $229.18
- P/E Ratio
- BKH $17.62
- QURE N/A
- Revenue Growth
- BKH 7.04
- QURE N/A
- 52 Week Low
- BKH $54.92
- QURE $5.50
- 52 Week High
- BKH $72.22
- QURE $71.50
- Technical
- Relative Strength Index (RSI)
- BKH 65.30
- QURE 36.57
- Support Level
- BKH $68.59
- QURE $25.24
- Resistance Level
- BKH $72.22
- QURE $31.16
- Average True Range (ATR)
- BKH 1.67
- QURE 3.74
- MACD
- BKH 0.26
- QURE -2.28
- Stochastic Oscillator
- BKH 73.58
- QURE 16.43
About BKH Black Hills Corporation
Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.